Literature DB >> 9013402

BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.

K Okumura1, H Ujike, K Akiyama, S Kuroda.   

Abstract

To clarify clinical roles of sigma receptor binding affinity of neuroleptics, neck dystonia induced by microinjection of sigma receptor ligands and neuroleptics into rat red nucleus was investigated. DTG and (+)-3-PPP, putative sigma receptor agonists, induced neck dystonia in dose-dependent and reversible manner. Haloperidol and perphenazine induced dystonia in the same way as sigma receptor agonists, whereas zotepine and (-)-sulpiride did not. The rank order of potency in induction of dystonia and sigma receptor affinity of these compounds showed positive correlation. Although BMY-14802 has a high affinity for sigma receptors, it never produced dystonia by itself. On the other hand, combined injection of BMY-14802 with DTG attenuated DTG-induced dystonia. Therefore, it is suggested that typical neuroleptics such as haloperidol act agonistic and atypical neuroleptics such as BMY-14802 act antagonistic at rubral sigma receptors in the induction of neck dystonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013402     DOI: 10.1007/BF01271200

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

Review 1.  Sigma receptors: from molecule to man.

Authors:  C D Ferris; D J Hirsch; B P Brooks; S H Snyder
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

Review 2.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

3.  BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent.

Authors:  R M Ferris; M Harfenist; G M McKenzie; B Cooper; F E Soroko; R A Maxwell
Journal:  J Pharm Pharmacol       Date:  1982-06       Impact factor: 3.765

4.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

5.  Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  J Neurosci       Date:  1986-06       Impact factor: 6.167

6.  Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.

Authors:  J P Yevich; J S New; D W Smith; W G Lobeck; J D Catt; J L Minielli; M S Eison; D P Taylor; L A Riblet; D L Temple
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

7.  An open study of remoxipride, a benzamide derivative, in schizophrenia.

Authors:  L Lindström; G Besev; G Stening; E Widerlöv
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

Authors:  S O Ogren; H Hall; C Köhler; O Magnusson; L O Lindbom; K Angeby; L Florvall
Journal:  Eur J Pharmacol       Date:  1984-07-20       Impact factor: 4.432

9.  Evidence for a role of haloperidol-sensitive sigma-'opiate' receptors in the motor effects of antipsychotic drugs.

Authors:  J M Walker; R R Matsumoto; W D Bowen; D L Gans; K D Jones; F O Walker
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

Review 10.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  4 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 2.  Animal models of focal dystonia.

Authors:  Craig Evinger
Journal:  NeuroRx       Date:  2005-07

3.  Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Authors:  Melanie A Paquette; Elizabeth G Brudney; Daniel B Putterman; Charles K Meshul; Steven W Johnson; Stephen Paul Berger
Journal:  Neuroreport       Date:  2008-01-08       Impact factor: 1.837

4.  The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Authors:  Melanie A Paquette; Katherine Foley; Elizabeth G Brudney; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Psychopharmacology (Berl)       Date:  2009-03-13       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.